Global Pharmaceuticals & Biotech Undervalued based on future growth

PharmaEssentia

Market Cap: NT$183.1b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$31.3b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

ACADIA Pharmaceuticals

Market Cap: US$4.0b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ADMA Biologics

Market Cap: US$3.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Organon

Market Cap: US$2.8b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Hypera

Market Cap: R$14.6b

Operates as a pharmaceutical company in Brazil.

Alvotech

Market Cap: US$2.5b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Harmony Biosciences Holdings

Market Cap: US$1.9b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Square Pharmaceuticals

Market Cap: ৳196.2b

Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.

Cosmo Pharmaceuticals

Market Cap: CHF 1.1b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Collegium Pharmaceutical

Market Cap: US$1.2b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Genomma Lab Internacional. de

Market Cap: Mex$19.9b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Strides Pharma Science

Market Cap: ₹81.8b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

SIGA Technologies

Market Cap: US$638.7m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Dong-A Socio Holdings

Market Cap: ₩731.1b

Engages in the pharmaceutical business in South Korea.

Boiron

Market Cap: €424.5m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Beximco Pharmaceuticals

Market Cap: ৳55.8b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

Essex Bio-Technology

Market Cap: HK$3.0b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$541.3m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Abeona Therapeutics

Market Cap: US$329.7m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

JBM (Healthcare)

Market Cap: HK$2.5b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

Egyptian International Pharmaceutical Industries

Market Cap: ج.م11.3b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

Newron Pharmaceuticals

Market Cap: CHF 178.7m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Chong Kun Dang Holdings

Market Cap: ₩235.4b

Manufactures and distributes pharmaceutical products in South Korea and internationally.

Protalix BioTherapeutics

Market Cap: US$144.3m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.3b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

Atara Biotherapeutics

Market Cap: US$85.1m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

EZZ Life Science Holdings

Market Cap: AU$104.3m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.

Earth Science Tech

Market Cap: US$58.6m

Together with its subsidies, focuses on health and wellness industry.

Decibel Cannabis

Market Cap: CA$75.0m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Neuphoria Therapeutics

Market Cap: US$24.5m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

Oncodesign Precision Medicine Société anonyme

Market Cap: €7.6m

A biopharmaceutical company, engages in the precision medicine business.